1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

Drug Promotion: M&A, Old Social Media Posts Can Increase Risk Of US FDA Enforcement

 
• By Sue Sutter

The loss of institutional knowledge about OPDP’s prior comments on promotional materials can result in an enforcement letter for the new owner of a company or product, experts say.

Elephant in the room
Like an elephant, the FDA never forgets what it tells sponsors about their promotional campaigns. (Shutterstock)

A drug company’s risk of receiving a promotion enforcement letter from the US Food and Drug Administration may increase with corporate mergers and acquisitions and a failure to clear away old advertising campaigns.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from FDLI